From Novel Conjugates to IND: Solving Early‑Phase CMC Challenges
- Lonza’s broad CMC experience across ADCs and emerging conjugate modalities enables de‑risked, accelerated early‑phase development to IND
- Real‑world customer use case: Resolving clearance liabilities and translating bench success into robust, scalable chromatography operations
- Fit‑for‑purpose analytics for complex conjugates: Closing method gaps to enable confident characterisation, release, and stability control